176 related articles for article (PubMed ID: 26719527)
1. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
[TBL] [Abstract][Full Text] [Related]
2. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
4. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
5. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
6. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
[TBL] [Abstract][Full Text] [Related]
7. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
[TBL] [Abstract][Full Text] [Related]
8. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.
Wang F; Liu H; Hu L; Liu Y; Duan Y; Cui R; Tian W
BMC Cancer; 2018 Apr; 18(1):360. PubMed ID: 29609556
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
Vaes RDW; van Dijk DPJ; Farshadi EA; Olde Damink SWM; Rensen SS; Langen RC
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1302-1313. PubMed ID: 35146962
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
11. SIRT1-NOX4 signaling axis regulates cancer cachexia.
Dasgupta A; Shukla SK; Vernucci E; King RJ; Abrego J; Mulder SE; Mullen NJ; Graves G; Buettner K; Thakur R; Murthy D; Attri KS; Wang D; Chaika NV; Pacheco CG; Rai I; Engle DD; Grandgenett PM; Punsoni M; Reames BN; Teoh-Fitzgerald M; Oberley-Deegan R; Yu F; Klute KA; Hollingsworth MA; Zimmerman MC; Mehla K; Sadoshima J; Tuveson DA; Singh PK
J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32441762
[TBL] [Abstract][Full Text] [Related]
12. The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Michaelis KA; Norgard MA; Zhu X; Levasseur PR; Sivagnanam S; Liudahl SM; Burfeind KG; Olson B; Pelz KR; Angeles Ramos DM; Maurer HC; Olive KP; Coussens LM; Morgan TK; Marks DL
Nat Commun; 2019 Oct; 10(1):4682. PubMed ID: 31615993
[TBL] [Abstract][Full Text] [Related]
13. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer.
Bye A; Wesseltoft-Rao N; Iversen PO; Skjegstad G; Holven KB; Ulven S; Hjermstad MJ
Med Oncol; 2016 Jun; 33(6):54. PubMed ID: 27119533
[TBL] [Abstract][Full Text] [Related]
14. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
17. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
18. Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia.
Parajuli P; Kumar S; Loumaye A; Singh P; Eragamreddy S; Nguyen TL; Ozkan S; Razzaque MS; Prunier C; Thissen JP; Atfi A
Dev Cell; 2018 Jun; 45(6):712-725.e6. PubMed ID: 29920276
[TBL] [Abstract][Full Text] [Related]
19. Metabolic signatures imaged in cancer-induced cachexia.
Penet MF; Gadiya MM; Krishnamachary B; Nimmagadda S; Pomper MG; Artemov D; Bhujwalla ZM
Cancer Res; 2011 Nov; 71(22):6948-56. PubMed ID: 21948967
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a cancer cachectic factor.
Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
